GLP-1 medicines cause malnutrition in 22% of patients. Multivitamins are often inadequate. Patients need dietitian support ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

As Ozempic reshapes the weight-loss landscape, doctors say there’s a crucial part of the story many users overlook until it’s ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...

Obese cats in a clinical trial will be given an implant that slowly releases a GLP-1 over three months.

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the ...